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A B S T R A C T
In Marfan syndrome, with dilatation of the aortic root secondary to an underlying connective tissue defect, pregnancy
can cause hemodynamic stress leading to the development of an aortic aneurysm and even a fatal aortic dissection. In the
presence of existing aortic root enlargement and a family history of aortic dissection, preventative elective surgery is sug-
gested. Aortic root replacement with or without a valve-sparing procedure is superior to total aortic root replacement with
prosthetic valve/tube graft. It provides excellent survival with low rates of aortic – valve related complications.
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Introduction
In Marfan syndrome, the myxoid degeneration of the
aortic root is often associated with idiopathic dilatation
of all parts of the aortic root: aortic annulus, sinuses of
Valsalva and sino-tubular junction. When a woman with
Marfan syndrome and annuloaortic ectasia coinciding
with an aneurysm or an aortic diameter greater than 5.5
cm, considers pregnancy, prophylactic aortic grafting sho-
uld be done1. Both short-term and long-term follow-up of
patients with Marfan syndrome are more favorable and
superior in those who had repair with the reimplantation
technique compared to those patients who had repair
with the remodeling (Bentall procedure). The David-I
procedure, repair of the aortic root aneurysm and preser-
vation of aortic native valve with reimplantation into
vascular graft, is the operation of choice in young females
with Marfan syndrome expecting pregnancy. This me-
thod helps to avoid the need for long-term anticoagula-
tion and may reduce the risk of stroke or endocarditis.
The current study presents the surgical procedure and
pregnancy outcome of a women with annulo-aortic dila-
tation in the setting of Marfan’s syndrome.
Case Report
A 25 year-old primigravida with Marfan syndrome
presented at her 33rd week of gestation to our hospital.
There was a positive history of Marfan syndrome in her
close family. Her mother and brother died from cardio-
vascular complications of Marfan syndrome at ages of 26
and 22, respectively. The patient had a 6 cm aneurysm of
her aortic root affecting the sinuses of Valsalva. The rest
of her ascending aorta, above the sino-tubular junction
was normal but the aortic wall was thin. She also had
moderate mitral and mild aortic and tricuspid regurgita-
tion with normally developed aortic valve leaflets. How-
ever, there was one stress fenestration of the commissure
between the non coronary and right coronary leaflets.
The coronary arteries were normal, coming from corre-
sponding sinuses. Her clinical presentation was typical
for Marfan syndrome and she was not on any medica-
tions. Two years prior, she underwent a valve-sparing
aortic root replacement with a 28 mm prostheses, David-
-I operation (Deutsches Kinderherzzentrum, Herz- und
Thoraxchirurgie, Sankt Augustin, Universität Bonn,
Bonn). Immediate postoperative echocardiographic as-
sessment was satisfactory. It showed normal aortic root
diameter, minimal aortic and moderate mitral regurgita-
tion. Left ventricular size and function were normal. The
fractional shortening was within normal limits, 30–32%.
Following surgery, the patient remained asymptomatic,
and was treated with atenolol and diuretics to reduce
risk of aortic dissection and post-operatively pleural ef-
fusion2. She stayed in close consultation with her cardiolo-
gist and took pre-pregnancy counselling at the regional
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genetic center. She conceived a year and a half after the
surgery and was in permanent antenatal care of her gy-
naecologist and cardiologist. The pregnancy course was
uneventful except for mild shortness of breath and fa-
tigue during her second trimester. Because of her comor-
bidities, her cardiologist recommended a delivery by cae-
sarean section. At admission in our hospital, her height
was 168 cm and weight was 57 kg. She had a long thin
face, limbs and digits, high arched palate, arachnoda-
ctyly, hypermobile joints and lens subluxation. Blood
pressure was 110/65 mmHg. ECG showed sinus rhythm
and a heart rate of 80 bpm. During her hospital stay, re-
peat echocardiography showed a normal aortic diameter,
moderate dilatation of the left atrium with normal con-
tractility and severe mitral regurgitation secondary to
mitral valve prolapse. Ejection fraction was normal up to
70%. The pressure in the right ventricle and pulmonary
artery was normal. At the 37th week of gestation, fetal
echocardiography showed normal fetal anatomy and nor-
mal fetal heart function. At the 39th week of pregnancy,
an elective caesarean section was performed under gen-
eral anaesthesia. She gave birth to a healthy boy weigh-
ing 3130 g with an Apgar score 10/10. Blood was taken
from the umbilical cord and was sent for genetic analysis.
Physical examination of the newborn was not suggestive
of Marfan syndrome and his cardiologic and ophthalmolo-
gic examinations were within normal limits. The patient’s
operative and postoperative course was uncomplicated.
Discussion
Marfan syndrome is an autosomal dominant disorder
with a prevalence of about 1–5 in 10,000. It is caused by a
mutation in the fibrillin-1 gene (FBN1), located on the
long arm of chromosome 15. The FBN1 gene is the major
constituent of microfibrils, which are components of the
extracellular matrix that are widely dispersed and per-
form numerous functions3–5.
Mutation of the FBN1 gene produces abnormal pro-
tein products which contribute to defective connective
tissue. Even with the discovery of the genetic and bio-
chemical bases of the condition, the diagnosis of Marfan
syndrome outside families with a classic phenotype re-
mains entirely clinical6,7. Marfan syndrome demonstra-
tes variable expressivity, pleiotropy, and a high rate of
new mutation. The condition is characterized by muscu-
loskeletal, cardiovascular and ocular manifestations. The
most common cardiovascular features are mitral valve
prolapse and dilatation of aortic root. If not treated, asso-
ciated clinical problems of mitral and aortic regurgita-
tion with aortic dissection, results in death for most pa-
tients in their fourth and fifth decades of life8. The most
common cause of death in adolescents or adults with
Marfan syndrome are rupture of fusiform aneurysms of
the ascending aorta, ascending aorta dissection and rup-
ture and congestive heart failure from aortic/or mitral
regurgitation. Beta blocker therapy, endocarditis prophy-
laxis, aorta and aortic valve surgery have probably im-
proved longevity9. Nevertheless, improved medical and
surgical management of such patients has added an aver-
age of 10–15 years to the expected life duration10. In addi-
tion to the maternal risk associated with pregnancy in
the Marfan syndrome, there is a 50:50 risk of having the
child who will inherit the syndrome. Furthermore, the
hyperdynamic and hypervolemic state of pregnancy in-
creases the risk of aortic dissection. The incidence of dis-
section is highest during the third trimester of pregnancy
and the first month postpartum11. Before pregnancy, wo-
men with Marfan syndrome should be assessed for car-
diovascular problems. The cause of the increased inci-
dence of aortic dissection during pregnancy is unclear,
but the combination of genetic predisposition to dissec-
tion and the hemodynamic stress during pregnancy may
have a role. Also, high levels of estrogen may cause inhi-
bition of collagen and elastin deposition in the aorta
too12,13. Finally, it has been shown that progesterone ac-
celerates deposition of noncollagenous proteins in the
aorta of the rats14.
Factors that can predispose patients to either aortic
aneurysm or aortic dissection include systemic arterial hy-
pertension, coarctation of aorta, pregnancy and trauma8.
The risk of aortic dissection or other cardiac complica-
tions is low when aortic root diameter does not exceed 40
mm and when a cardiac function is not compromised. If
the diameter of the aortic root exceeds 40 mm, there is a
10% risk of dissecting aneurysm of the aorta12,15. Surgical
repair is generally recommended when the diameter
reaches 55 to 60 mm and probably earlier if there is rapid
progression or a family history of aortic dissection or
rupture16. The risk of pregnancy in women who have had
replacement of the aortic root is still unknown.
Conclusion
Treatment strategies for aortic root dilatation in pa-
tients with Marfan syndrome include both medical and
surgical approaches. An aortic root diameter  40 mm is
considered to be associated with a favorable outcome of
pregnancy. Prophylactic therapy with beta blockers and
hidralazyne has been advocated14. If aortic root diameter
is greater than 40mm and family history is positive for
aortic dissection, as was the case with our patient, then
an elective root replacement surgery is recommended be-
fore pregnancy. In our case, surgical treatment prior to
pregnancy and appropriate preconception counseling we-
re imperative for good maternal17,18 and fetal outcome.
Additionally, in patients with aortic root dilatation, mod-
erate/severe mitral regurgitation, aortic aneurysm or
other cardiac abnormalities, cesarean section should be
the preferred method of delivery because it minimizes
the hemodynamic stress present in vaginal delivery. Suc-
cessful pregnancy can be expected after a more physio-
logical valve- sparing aortic root replacement.
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ISHOD TRUDNO]E NAKON PREVENTIVNE ZAMJENE AORTNOG KORIJENA UZ O^UVANJE
AORTNE VALVULE KOD MARFANOVOG SINDROMA
S A @ E T A K
Kod Marfanovog sindroma s dilatiranim aortnim korijenom kao posljedicom defektnog vezivnog tkiva, trudno}a
predstavlja kemodinamski stres koji mo`e dovesti do razvoja aneurizme aorte ili ~ak fatalne aortne disekcije. Kod tako-
vih pacijenata s verificiranom dilatacijom aortnog korijena i pozitivnom obiteljskom anamnezom za aortnu disekciju,
preporu~a se u~initi elektivni kirur{ki zahvat zamijene aortnog korijena s o~uvanjem valvule, koji je superioran u odno-
su na cjelovitu zamjenu aortnog korijena protetskom valvulom/cjevnim graftom. Takav zahvat osigurava izvrsno pre-
`ivljenje s niskom razinom komplikacija posebice tijekom izlo`enosti stresogenim faktorima kao {to je trudno}a.
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